Hemant Surgical

Which are the latest news on Hemant Surgical?

Why is Hemant Surgical Industries Ltd falling/rising?

As of 05-Sep, Hemant Surgical Industries Ltd's stock price is rising to 372.35, reflecting a 1.0% increase. This upward trend is supported by strong performance against its sector, consistent gains over the past two days, and increased investor participation.

As of 05-Sep, Hemant Surgical Industries Ltd's stock price is rising, currently at 372.35, reflecting an increase of 3.7 (1.0%). This upward movement can be attributed to several factors. The stock has outperformed its sector by 2.44% today and has shown a consecutive gain over the last two days, accumulating a total return of 3.86% during this period. Additionally, Hemant Surgical is trading above its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a strong bullish trend.<BR><BR>Investor participation has also increased, with a delivery volume of 11.6k on September 3, which is a rise of 16.94% compared to the 5-day average delivery volume. This suggests growing interest and confidence among investors in the stock. Overall, these factors contribute to the positive momentum in Hemant Surgical Industries Ltd's stock price.

Who are in the management team of Hemant Surgical?

The management team of Hemant Surgical includes Hanskumar Shamji Shah (Chairman & Managing Director), Hemant Praful Shah (Whole-time Director), Hans Kaushik Kumar Shah (Whole Time Director & CFO), Nehal Babu Kareliya (Director), Pooja (Independent Director), Sourabh Ajmera (Independent Director), and Meenal Ajmera (Company Secretary & Compliance Officer). They are responsible for the company's operations and strategic direction.

The management team of Hemant Surgical includes the following key members:<BR><BR>1. **Hanskumar Shamji Shah** - Chairman & Managing Director<BR>2. **Hemant Praful Shah** - Whole-time Director<BR>3. **Hans Kaushik Kumar Shah** - Whole Time Director & CFO<BR>4. **Nehal Babu Kareliya** - Director<BR>5. **Pooja** - Independent Director<BR>6. **Sourabh Ajmera** - Independent Director<BR>7. **Meenal Ajmera** - Company Secretary & Compliance Officer<BR><BR>This team plays a crucial role in overseeing the company's operations and strategic direction.

What does Hemant Surgical do?

Hemant Surgical Industries Ltd is a Micro Cap company in the Healthcare Services sector, specializing in medical equipment and supplies. It was incorporated in 1989 and has a market cap of INR 545 Cr, with key metrics including a P/E of 29.00 and a return on equity of 14.34%.

Overview: <BR>Hemant Surgical Industries Ltd is engaged in the business of Medical Equipment & Supplies and operates within the Healthcare Services industry, classified as a Micro Cap company.<BR><BR>History: <BR>Hemant Surgical Industries Ltd was originally incorporated as "Hemant Surgical Industries Private Limited" on March 27, 1989. The company later converted to a public limited company and changed its name to "Hemant Surgical Industries Limited" on February 22, 1994. There is no recent sales or profit data available.<BR><BR>Financial Snapshot: <BR>Most recent Net Sales: N/A <BR>Most recent Net Profit: N/A <BR>Market-cap value: INR 545 Cr (Micro Cap)<BR><BR>Key Metrics: <BR>P/E: 29.00 <BR>Industry P/E: 67 <BR>Dividend Yield: 0.00% <BR>Debt-Equity: 0.05 <BR>Return on Equity: 14.34% <BR>Price-to-Book: 4.24 <BR><BR>Contact Details: <BR>Registrar Address: Not available. <BR>Phone: N/A <BR>Email: N/A <BR>Website: N/A

Who are the peers of the Hemant Surgical?

Hemant Surgical's peers include Laxmi Dental, One Global Serv, Health X Platfor, Prevest Denpro, Nureca, Take, and QMS Medical. Notably, One Global Serv shows excellent management and capital structure, while Hemant Surgical has good growth and a 1-year return of 23.68%.

Peers: The peers of Hemant Surgical are Laxmi Dental, One Global Serv, Health X Platfor, Prevest Denpro, Nureca, Take, and QMS Medical.<BR><BR>Quality Snapshot: Excellent management risk is observed at One Global Serv and Prevest Denpro, while Average management risk is found at Laxmi Dental, Hemant Surgical, and QMS Medical. Good growth is noted at Laxmi Dental, One Global Serv, and Hemant Surgical, while Below Average growth is seen at Health X Platfor, Prevest Denpro, Nureca, and Take. Excellent capital structure is present at One Global Serv, Health X Platfor, and Prevest Denpro, while Good capital structure is noted at Hemant Surgical and Nureca, and Average capital structure is found at Laxmi Dental, Take, and QMS Medical.<BR><BR>Return Snapshot: One Global Serv has the highest 1-year return at 111.18%, while Prevest Denpro has the lowest at -32.25%. Hemant Surgical's 1-year return of 23.68% is significantly higher than Prevest Denpro's but lower than One Global Serv's. Additionally, the six-month return is negative for Laxmi Dental, Prevest Denpro, Take, and QMS Medical.

How big is Hemant Surgical?

As of 14th August, Hemant Surgical Industries Ltd has a market capitalization of 534.00 Cr, classified as a Micro Cap. There is no valid financial data available for Net Sales and Net Profit for the latest four quarters.

As of 14th August, <BR><BR>Market Cap: Hemant Surgical Industries Ltd has a market capitalization of 534.00 Cr, classified as a Micro Cap.<BR><BR>Recent Quarterly Performance: There is no valid financial data available for Net Sales and Net Profit for the latest four quarters.<BR><BR>Balance Sheet Snapshot: The reporting period is March 2025, with Shareholder's Funds amounting to 63.17 Cr and Total Assets totaling 148.15 Cr.

Is Hemant Surgical overvalued or undervalued?

As of December 1, 2025, Hemant Surgical is considered overvalued with a PE ratio of 43.61 and elevated EV ratios compared to peers, despite a strong year-to-date return of 115.49%.

As of 1 December 2025, Hemant Surgical's valuation grade has moved from fair to expensive, indicating a shift towards overvaluation. The company's current PE ratio stands at 43.61, while its EV to EBITDA ratio is 36.83, and the EV to Sales ratio is 3.14. These figures suggest that Hemant Surgical is trading at a premium compared to its earnings and sales, which raises concerns about its valuation.<BR><BR>In comparison to its peers, Hemant Surgical's valuation appears high, especially when juxtaposed with Apollo Hospitals, which has a PE ratio of 62.66 and an EV to EBITDA of 32.97, marking it as attractive. Other competitors like Narayana Hrudaya and Max Healthcare are also valued higher, with PE ratios of 45.9 and 77.91, respectively. Given these comparisons and the elevated ratios, Hemant Surgical is deemed overvalued in the current market context. Notably, the company has outperformed the Sensex with a year-to-date return of 115.49%, but this performance does not mitigate the concerns surrounding its current valuation.

How has been the historical performance of Hemant Surgical?

For the fiscal year ending March 2025, Hemant Surgical reported an operating income of 106.64 crore and a net profit of 8.04 crore, with total assets and liabilities both at 148.15 crore. The company had a cash flow from operating activities of 8.00 crore, resulting in a closing cash balance of 9.00 crore.

Answer:<BR>The historical performance of Hemant Surgical for the year ending March 2025 shows a total operating income of 106.64 crore, with a net profit after tax of 8.04 crore. The company reported an operating profit margin of 8.42% and a profit after tax margin of 7.54%. The earnings per share stood at 7.7, and the book value per share was 60.51. Total liabilities were recorded at 148.15 crore, with total assets also at 148.15 crore, indicating a balanced position. The cash flow from operating activities was 8.00 crore, while the net cash outflow for the period was 3.00 crore, resulting in a closing cash and cash equivalent of 9.00 crore.<BR><BR>Breakdown:<BR>In the fiscal year ending March 2025, Hemant Surgical achieved a total operating income of 106.64 crore, primarily driven by net sales. The company faced raw material costs of 94.26 crore, leading to a total expenditure of 97.66 crore, which resulted in an operating profit (PBDIT) of 14.10 crore. After accounting for interest and depreciation, the profit before tax was reported at 10.47 crore, culminating in a profit after tax of 8.04 crore. The company's total liabilities and total assets were both recorded at 148.15 crore, reflecting a stable financial position. The cash flow analysis indicated a cash flow from operating activities of 8.00 crore, but an overall net cash outflow of 3.00 crore, leaving a closing cash balance of 9.00 crore.

Who are the top shareholders of the Hemant Surgical?

The top shareholders of Hemant Surgical include Hanskumar Shamji Shah with 33.78%, followed by Carnelian Structural Shift Fund at 1.11%, and individual investors holding 20.87%. There are no pledged promoter holdings, and one Foreign Institutional Investor holds 0.39%.

The top shareholders of Hemant Surgical include the promoters, with Hanskumar Shamji Shah holding the largest share at 33.78%. There are no pledged promoter holdings, and the company has one Foreign Institutional Investor (FII) holding 0.39%. The highest public shareholder is Carnelian Structural Shift Fund, which holds 1.11%. Additionally, individual investors collectively hold 20.87% of the shares.

What is the technical trend for Hemant Surgical?

As of June 3, 2025, Hemant Surgical's trend has shifted to bearish, driven by daily moving averages and Bollinger Bands indicating bearish momentum, despite a mildly bullish MACD signal on the weekly chart.

As of 3 June 2025, the technical trend for Hemant Surgical has changed from mildly bearish to bearish. The current stance is bearish with moderate strength, primarily driven by the daily moving averages indicating bearish momentum and the Bollinger Bands showing a bearish signal on both weekly and monthly time frames. The Dow Theory also supports a mildly bearish outlook on the weekly and monthly charts. While the MACD shows a mildly bullish signal on the weekly, it is not strong enough to counter the overall bearish indicators. The stock has underperformed significantly against the Sensex over multiple time frames, further reinforcing the bearish sentiment.

When is the next results date for Hemant Surgical?

No Upcoming Board Meetings

Has Hemant Surgical declared dividend?

No Dividend History Available